Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018

SELL
$5.43 - $8.36 $923,881 - $1.42 Million
-170,144 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$8.15 - $10.55 $414,883 - $537,058
50,906 Added 42.69%
170,144 $1.39 Million
Q3 2017

Nov 13, 2017

BUY
$10.45 - $11.44 $35,112 - $38,438
3,360 Added 2.9%
119,238 $1.25 Million
Q2 2017

Aug 11, 2017

BUY
N/A
115,878
115,878 $1.28 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $50.2M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Millrace Asset Group, Inc. Portfolio

Follow Millrace Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.